ArticleCancers2025

Correction: Lan et al. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer.

Bin Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.